Financials

  • Market Capitalization 1.85 B
  • Employee 99
  • Founded 2019
  • CEO N/A
  • Website www.tayshagtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00TJXFDP1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-16.21
Relación precio/flujo de caja
396.94

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2043
IMCR
Immunocore Holdings plc - American Depositary Shares
36.32 USD-0.82%-0.49%+7.46%+8.48%1.87 B USD
2044
INBX
Inhibrx Biosciences, Inc. - Common Stock
126.70 USD+2.67%+19.56%+54.78%+57.24%1.86 B USD
2048
VIR
Vir Biotechnology, Inc. - Common Stock
10.94 USD+1.02%+9.07%+25.17%+82.94%1.85 B USD
2065
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.40 USD+1.80%+3.98%+12.21%-25.93%1.82 B USD

Noticias